✦ LIBER ✦

P-096: Regulation of neuroprotective proteins BCL2 and GSK3 in leukocytes from valproate-treated patients with Alzheimer’s disease

✍ Scribed by Rebekah Loy; Louis Profenno; Connie Holt; Cindy Casaceli; Timothy Mhyre; Paul Coleman; Howard Federoff; Pierre Tariot

Book ID: 118463437
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 46 KB
Volume: 3
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2007.04.349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

516 Expression of protein kinase GSK-3 a

516 Expression of protein kinase GSK-3 and protein phosphatases PP-1, PP 2A, and PP-2B in the brain of patients with Alzheimer's disease

✍ J.-J. Pei; T. Tanaka; C.-X. Gong; E. Braak; R.F. Cowburn; B. Winblad; K. Iqbal; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Decreased levels of PSD95 and two associ

Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Aβ, and neurodegeneration in a prodromal stage of Alzheimer's disease

✍ Rukhsana Sultana; William A. Banks; D. Allan Butterfield 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract Alzheimer's disease (AD) is the most common form of dementia and is pathologically characterized by senile plaques, neurofibrillary tangles, synaptic disruption and loss, and progressive neuronal deficits. The exact mechanism(s) of AD pathogenesis largely remain unknown. With advances i